STOCK TITAN

Zoetis to Participate in the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Zoetis (NYSE:ZTS) will participate in the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022. CEO Kristin Peck is scheduled to present at 1:30 p.m. ET and will answer questions from analysts. Interested investors can access a live audio webcast of the presentation at http://investor.zoetis.com/events-presentations, with a replay available afterward. Zoetis is a leading animal health company with a revenue of $6.7 billion in 2020, supporting animal care globally.

Positive
  • None.
Negative
  • None.

PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 10, 2022. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 1:30 p.m. ET.

Investors and other interested parties will be able to access a live audio webcast of the virtual presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After nearly 70 years innovating ways to predict, prevent, detect, and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide -- from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $6.7 billion in 2020 with approximately 11,300 employees. For more information, visit www.zoetis.com.

ZTS-CORP
ZTS-IR

Media

Bill Price

1-973-443-2742 (o)

william.price@zoetis.com

Kristen Seely

1-973-443-2777 (o)

kristen.seely@zoetis.com

Investor

Steve Frank

1-973-822-7141 (o)

steve.frank@zoetis.com

Keith Gaub

1-973-822-7154 (o)

keith.gaub@zoetis.com

Source: Zoetis Inc.

FAQ

When will Zoetis participate in the J.P. Morgan Healthcare Conference?

Zoetis will participate in the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022.

Who is representing Zoetis at the J.P. Morgan Healthcare Conference?

CEO Kristin Peck will represent Zoetis at the conference.

At what time is Zoetis' presentation scheduled during the conference?

Zoetis' presentation is scheduled for 1:30 p.m. ET on January 10, 2022.

How can I access the Zoetis presentation at the conference?

The Zoetis presentation can be accessed via a live audio webcast at http://investor.zoetis.com/events-presentations.

What was Zoetis' revenue in 2020?

Zoetis generated $6.7 billion in revenue in 2020.

ZOETIS INC.

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Stock Data

78.33B
451.17M
0.2%
96.44%
0.97%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
PARSIPPANY